Natalia Kuklina

Natalia Kuklina is a seasoned professional in the pharmaceutical industry with extensive experience in commercial operations and market research. Currently serving as the Commercial Operations Director for BeNeLux at Gilead Sciences since January 2018, Natalia leads cross-functional teams for the launch of hepatitis Delta treatments in the Netherlands, following a notable tenure at AstraZeneca from 2011 to 2017, where various leadership roles were held, including Head of Commercial Excellence. Previous positions at sanofi-aventis and Dr. Reddy's Laboratories refined Natalia's expertise in market research, strategic planning, and marketing operations. Educational qualifications include an MBA from IEDC - Bled School of Management and master's degrees in Marketing and Management.